BSE: JBCHEPHARM - J. B. Chemicals & Pharmaceuticals Limited

Altı ay boyunca karlılık: -20.19%
Temettü getirisi: +0.73%

Promosyon programı J. B. Chemicals & Pharmaceuticals Limited


Şirket hakkında J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.

daha fazla ayrıntı
It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

ISIN INE572A01028
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.6872
Дивиденд ао 15.25
Сайт https://www.jbpharma.com
Цена ао 1518
Haftalık fiyat değişimi: -3.77% (1577.4)
Aylık fiyat değişimi: -6.72% (1627.3)
3 ayda fiyat değişimi: -17.54% (1840.85)
Altı ayda fiyat değişimi: -20.19% (1902)
Yıllık fiyat değişimi: -2.02% (1549.25)
3 yılda fiyat değişimi: -3.32% (1570.1)
5 yılda fiyat değişimi: +205.74% (496.5)
Yılbaşından bu yana fiyat değişimi: -19.89% (1894.9)

Hafife alma

İsim Anlam Seviye
P/S 7.25 1
P/BV 8.55 1
P/E 45.21 3
EV/EBITDA 5.46 9
Toplam: 5.13

Yeterlik

İsim Anlam Seviye
ROA, % 14.64 4
ROE, % 20.45 7
Toplam: 6.33

Temettüler

İsim Anlam Seviye
Div yield, % 0.729 1.83
DSI 0.8571 8.57
Toplam: 3.75

Görev

İsim Anlam Seviye
Debt/EBITDA 0.124 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 97.83 9
karlılık Ebitda, % 731 10
karlılık EPS, % 106.67 10
Toplam: 9.8

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Nikhil Ashokkumar Chopra CEO & Whole-Time Director 65.45M 1973 (52 yıl)
Mr. Kunal Khanna President of Operations N/A 1980 (45 yıllar)
Mr. Sridhar Bharadwaj Vice President of HR & Administration N/A 1967 (58 yıllar)
Mr. Pradeep Kumar Singh President of Global Business N/A 1964 (61 yıl)
Mr. Himanshu Ranvah Vice President of Legal N/A 1985 (40 yıllar)
Mr. Parmeshwar B. Bang Executive Vice President of Operations of Daman N/A 1968 (57 yıllar)
Suresh Amin Assistant Vice President ? Human Resource
Mr. Narayan Saraf Chief Financial Officer 1980 (45 yıllar)
Mr. Bhagwat Singh Deora Vice President of Finance & Accounts 1982 (43 yıl)
Mr. Suresh Bhise Vice President of Information & Technology 1966 (59 yıllar)

Adres: India, Mumbai, Cnergy IT Park - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.jbpharma.com